Bioadaptives (BDPT) Total Current Liabilities (2013 - 2026)

Bioadaptives has disclosed Total Current Liabilities across 13 years of filings, most recently posting $2.3 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $2.3 million, up 35.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (up 35.12% YoY), and the FY2025 annual result was $2.4 million, up 36.51% from the prior year.
• Total Current Liabilities came in at $2.3 million for Q1 2026 at Bioadaptives, down from $2.4 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $2.4 million in Q4 2025 to a low of $1.4 million in Q2 2025.
• The 5-year median for Total Current Liabilities is $1.7 million (2025), against an average of $1.7 million.
• Peak annual rise in Total Current Liabilities reached 36.51% in 2025, while the deepest fall reached 27.07% in 2025.
• Bioadaptives' Total Current Liabilities stood at $1.5 million in 2022, then advanced by 17.59% to $1.8 million in 2023, then dropped by 1.42% to $1.7 million in 2024, then soared by 36.51% to $2.4 million in 2025, then fell by 3.56% to $2.3 million in 2026.
• The last three Total Current Liabilities figures came in at $2.3 million (Q1 2026), $2.4 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.